Drug
Enzastaurin hydrochloride clinical trials
Also written Enzastaurin HCl.
A product of Enzastaurin; its studies count on that page too.
How studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2006 (3)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 1 |
| 2018 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 5
Eli Lilly and Company (4) · Denovo Biopharma LLC (2) · Eastern Cooperative Oncology Group (2) · Gynecologic Oncology Group (1) · Pediatric Brain Tumor Consortium (1) · European Organisation for Research and Treatment of Cancer - EORTC (1)
Often tested with
Tested in the same studies.
Bevacizumab (2) · Temozolomide (1) · Carboplatin (1) · Gemcitabine (1)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Enzastaurin
- One of Protein Kinase Inhibitors source
Studies
Open first, then newest update. How each study uses enzastaurin hydrochloride is read from its arms, and is right about nine times in ten.
Testing it · 11
- Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™CompletedPhase 3Denovo Biopharma LLCNCT03263026Written as Enzastaurin Hydrochloride
- A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1CompletedPhase 3Denovo Biopharma LLCNCT03776071Written as Enzastaurin Hydrochloride
- Enzastaurin for Patients With Metastatic Colorectal CancerCompletedPhase 2Eli Lilly and CompanyNCT00192114Written as Enzastaurin HCl
- Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedPhase 2Gynecologic Oncology GroupNCT00407758Written as enzastaurin hydrochloride
- Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung CancerWithdrawnPhase 2Eastern Cooperative Oncology GroupNCT00469976Written as enzastaurin hydrochloride
- Enzastaurin and Temozolomide in Treating Patients With Primary GliomasStatus unknownPhase 1European Organisation for Research and Treatment of Cancer - EORTCNCT00516607Written as enzastaurin hydrochloride
- Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate CancerWithdrawnPhase 2Eastern Cooperative Oncology GroupNCT00685633Written as enzastaurin hydrochloride
- Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic CancerCompletedPhase 1Eli Lilly and CompanyNCT00550927Written as enzastaurin hydrochloride
- Enzastaurin in Treating Young Patients With Refractory Primary CNS TumorsCompletedPhase 1Pediatric Brain Tumor ConsortiumNCT00503724Written as enzastaurin hydrochloride
- Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane ChemotherapyCompletedPhase 2Eli Lilly and CompanyNCT00386087Written as Enzastaurin Hydrochloride
- Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.CompletedPhase 2Eli Lilly and CompanyNCT00105092Written as Enzastaurin HCL
Codes
What other systems call enzastaurin hydrochloride · ClinicalTrials.gg INT017106
- UNII (FDA) KX7K68Z2UHENZASTAURIN HYDROCHLORIDEConfirmed FDA, Wikidata
- Wikidata Q27282481enzastaurin hydrochlorideConfirmed FDA, Wikidata
- NCI Thesaurus C26658Enzastaurin HydrochlorideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | KX7K68Z2UH | ENZASTAURIN HYDROCHLORIDE | Confirmed FDA, Wikidata |
| Wikidata | Q27282481 | enzastaurin hydrochloride | Confirmed FDA, Wikidata |
| NCI Thesaurus | C26658 | Enzastaurin Hydrochloride | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.